Iqvia Holdings INC Form 4 insider transactions
Insider transactions: buys and sells by directors, officers and ten percent owners, filed within two business days of the trade.
NYSE
W Richard Staub, See Remarks of Iqvia Holdings Inc., sold 5,500 shares of common stock on August 3, 2026 for $232.68 per share.
NYSE
Eric Sherbet, See Remarks of Iqvia Holdings Inc., sold 5,000 shares of common stock on July 29, 2026 for $249.16 per share.
NYSE
Keriann Cherofsky, See Remarks of Iqvia Holdings Inc., sold 558 shares of common stock on July 29, 2026 for $245.21 per share.
NYSE
Ari Bousbib, See Remarks and a Director of Iqvia Holdings Inc., sold 106,279 shares of common stock on July 29, 2026.
NYSE
Morris Leslie Wims, a Director of Iqvia Holdings Inc., received 148 shares of common stock on July 14, 2026.
NYSE
Colleen A Goggins, a Director of Iqvia Holdings Inc., received 183 shares of common stock on July 14, 2026.
NYSE
Jim Fasano, a Director of Iqvia Holdings Inc., received 195 shares of common stock on July 14, 2026.
NYSE
John G Danhakl, a Director of Iqvia Holdings Inc., received 160 shares of common stock on July 14, 2026.
NYSE
Leslie Wims Morris, a Director at IQVIA Holdings Inc., reported a transaction involving deferred shares convertible into common stock.
NYSE
Colleen Goggins, a Director at IQVIA Holdings Inc., reported a transaction involving deferred shares convertible into common stock.
NYSE
Jim Fasano, a Director at IQVIA Holdings Inc., acquired 228 deferred shares on May 7, 2026, as part of the company's Non-Employee Director Deferral Plan.
NYSE
John G. Danhakl, a Director at IQVIA Holdings Inc., acquired 185 deferred shares valued at $178.64 each, as reported in a Form 4 filing.
NYSE
IQVIA Holdings Inc. director Sheila A. Stamps acquired 1,571 deferred shares as part of the company's non-employee director compensation plan.
NYSE
IQVIA Holdings Inc. director Leslie Wims Morris acquired 1,571 deferred shares as part of the company's non-employee director compensation plan.
NYSE
IQVIA Holdings Inc. director William G. Kaelin Jr. was granted 1,571 deferred shares as part of director compensation.
NYSE
Director John M. Leonard acquired 1,571 shares of IQVIA Holdings Inc. common stock as part of a non-employee director award.
NYSE
IQVIA Holdings Inc. director Colleen A. Goggins acquired 1,571 shares of common stock as part of a non-employee director equity award.
NYSE
Director Jim Fasano acquired 1,571 deferred shares of IQVIA Holdings Inc. as part of the company's non-employee director compensation plan.
NYSE
IQVIA Holdings Inc. director John G. Danhakl acquired 1,571 shares of common stock as part of a non-employee director equity award.
NYSE
Director Carol Burt acquired 1,571 shares of IQVIA Holdings Inc. common stock as part of a non-employee director award.
NYSE
IQVIA Holdings Inc. officer W. Richard Staub was granted 26,088 Stock Appreciation Rights with a strike price of $192.67, vesting over three years.
NYSE
IQVIA Holdings Inc.'s Executive Vice President and General Counsel, Eric Sherbet, was granted 12,112 Stock Appreciation Rights on February 9, 2026.
NYSE
IQVIA Holdings Inc. officer Bhavik Patel received a grant of 11,180 Stock Appreciation Rights with a strike price of $192.67, vesting annually from February 2027.
NYSE
IQVIA Holdings Inc. EVP Bernd Haas received a grant of 11,180 Stock Appreciation Rights with a $192.67 exercise price, vesting over three years.
NYSE
Alistair Grenfell, President of Commercial Solutions at IQVIA Holdings Inc., was granted 26,088 stock appreciation rights with a strike price of $192.67.
NYSE
Michael J. Fedock, SVP, FP&A at IQVIA Holdings Inc., was granted 18,634 Stock Appreciation Rights with a strike price of $192.67.
NYSE
IQVIA Holdings Inc.'s SVP, Corporate Controller, Keriann Cherofsky, was granted 2,795 Stock Appreciation Rights with an exercise price of $192.67.
NYSE
IQVIA Holdings Inc. executive James G. Berkshire was granted 11,180 Stock Appreciation Rights with a strike price of $192.67, vesting over three years.
NYSE
IQVIA Holdings Inc. CEO Ari Bousbib was granted 78,264 stock appreciation rights, vesting annually starting February 2027.
NYSE
IQVIA Holdings Inc. Director Morris Leslie Wims acquired 159 deferred shares, increasing total beneficial ownership to 4,894 deferred shares.